These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7507814)

  • 1. Absorption, metabolism, and excretion of risperidone in humans.
    Mannens G; Huang ML; Meuldermans W; Hendrickx J; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1993; 21(6):1134-41. PubMed ID: 7507814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism and excretion of risperidone after oral administration in rats and dogs.
    Meuldermans W; Hendrickx J; Mannens G; Lavrijsen K; Janssen C; Bracke J; Le Jeune L; Lauwers W; Heykants J
    Drug Metab Dispos; 1994; 22(1):129-38. PubMed ID: 7512019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans.
    Vermeir M; Naessens I; Remmerie B; Mannens G; Hendrickx J; Sterkens P; Talluri K; Boom S; Eerdekens M; van Osselaer N; Cleton A
    Drug Metab Dispos; 2008 Apr; 36(4):769-79. PubMed ID: 18227146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of risperidone in humans: a summary.
    Heykants J; Huang ML; Mannens G; Meuldermans W; Snoeck E; Van Beijsterveldt L; Van Peer A; Woestenborghs R
    J Clin Psychiatry; 1994 May; 55 Suppl():13-7. PubMed ID: 7520903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
    Colizza K; Awad M; Kamel A
    Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
    Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
    Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion and biotransformation of cisapride in dogs and humans after oral administration.
    Meuldermans W; Van Peer A; Hendrickx J; Lauwers W; Swysen E; Bockx M; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1988; 16(3):403-9. PubMed ID: 2900732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of risperidone in chronic schizophrenic patients.
    Borison RL; Diamond B; Pathiraja A; Meibach RC
    Psychopharmacol Bull; 1994; 30(2):193-7. PubMed ID: 7530379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, metabolism and excretion of ketanserin in man after oral administration.
    Meuldermans W; Hendrickx J; Woestenborghs R; Van Peer A; Lauwers W; De Cree J; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):789-94. PubMed ID: 3178919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone.
    Nyberg S; Dahl ML; Halldin C
    Psychopharmacology (Berl); 1995 Jun; 119(3):345-8. PubMed ID: 7545821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.